Type 17 immunity promotes the exhaustion of CD8(+) T cells in cancer

Cited 0 time in webofscience Cited 0 time in scopus
  • Hit : 60
  • Download : 0
Background Multiple types of immune cells producing IL-17 are found in the tumor microenvironment. However, their roles in tumor progression and exhaustion of CD8(+) tumor-infiltrating lymphocytes (TILs) remain unclear. Methods To determine the role of type 17 immunity in tumor, we investigated the growth of B16F10 melanoma and the exhaustion of CD8(+) TILs in Il17a (-/-) mice, Il17a (Cre) R26 (DTA) mice, ROR gamma t inhibitor-treated mice, or their respective control mice. Adoptive transfer of tumor-specific IL-17-producing T cells was performed in B16F10-bearing congenic mice. Anti-CD4 or anti-Ly6G antibodies were used to deplete CD4(+) T cells or CD11b(+)Gr-1(hi) myeloid cells in vivo, respectively. Correlation between type 17 immunity and T cell exhaustion in human cancer was evaluated by interrogating TCGA dataset. Results Depletion of CD4(+) T cells promotes the exhaustion of CD8(+) T cells with a concomitant increase in IL-17-producing CD8(+) T (Tc17) cells in the tumor. Unlike IFN-gamma-producing CD8(+) T (Tc1) cells, tumor-infiltrating Tc17 cells exhibit CD103(+)KLRG1(-)IL-7R alpha(hi) tissue resident memory-like phenotypes and are poorly cytolytic. Adoptive transfer of IL-17-producing tumor-specific T cells increases, while depletion of IL-17-producing cells decreases, the frequency of PD-1(hi)Tim3(+)TOX(+) terminally exhausted CD8(+) T cells in the tumor. Blockade of IL-17 or ROR gamma t pathway inhibits exhaustion of CD8(+) T cells and also delays tumor growth in vivo. Consistent with these results, human TCGA analyses reveal a strong positive correlation between type 17 and CD8(+) T cell exhaustion signature gene sets in multiple cancers. Conclusion IL-17-producing cells promote terminal exhaustion of CD8(+) T cells and tumor progression in vivo, which can be reversed by blockade of IL-17 or ROR gamma t pathway. These findings unveil a novel role for IL-17-producing cells as tumor-promoting cells facilitating CD8(+) T cell exhaustion, and propose type 17 immunity as a promising target for cancer immunotherapy.
Publisher
BMJ PUBLISHING GROUP
Issue Date
2021-06
Language
English
Article Type
Article
Citation

JOURNAL FOR IMMUNOTHERAPY OF CANCER, v.9, no.6

ISSN
2051-1426
DOI
10.1136/jitc-2021-002603
URI
http://hdl.handle.net/10203/286010
Appears in Collection
BS-Journal Papers(저널논문)MSE-Journal Papers(저널논문)
Files in This Item
There are no files associated with this item.

qr_code

  • mendeley

    citeulike


rss_1.0 rss_2.0 atom_1.0